<?xml version="1.0" encoding="UTF-8"?>
<feed xml:lang="en-US" xmlns="http://www.w3.org/2005/Atom">
  <id>tag:bio-v2.katalyst.com.au,2005:/business_news/feed</id>
  <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au"/>
  <link rel="self" type="application/atom+xml" href="http://bio-v2.katalyst.com.au/business_news/feed.atom"/>
  <title>BioSA Industry News</title>
  <updated>2012-08-06T04:43:49Z</updated>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/149</id>
    <published>2012-08-06T04:43:49Z</published>
    <updated>2012-08-06T04:43:49Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/portable-device-detects-soil-contamination"/>
    <url>http://bio-v2.katalyst.com.au/news_items/portable-device-detects-soil-contamination</url>
    <title>Portable Device Detects Soil Contamination</title>
    <content type="html">Portable Device Detects Soil Contamination</content>
    <updated>2012-08-06T04:43:49Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/148</id>
    <published>2012-08-06T04:43:49Z</published>
    <updated>2012-08-06T04:43:49Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/calpain-therapeutics-wins-proof-of-concept-grant-for-cataract-treatment"/>
    <url>http://bio-v2.katalyst.com.au/news_items/calpain-therapeutics-wins-proof-of-concept-grant-for-cataract-treatment</url>
    <title>Calpain Therapeutics Wins Proof of Concept Grant for Cataract Treatment</title>
    <content type="html">Calpain Therapeutics Wins Proof of Concept Grant for Cataract Treatment</content>
    <updated>2012-08-06T04:43:49Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/143</id>
    <published>2012-08-06T04:39:09Z</published>
    <updated>2012-08-06T04:39:09Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/six-flinders-university-staff-make-sa-science-excellence-awards-finals"/>
    <url>http://bio-v2.katalyst.com.au/news_items/six-flinders-university-staff-make-sa-science-excellence-awards-finals</url>
    <title>Six Flinders University Staff Make SA Science Excellence Awards Finals  </title>
    <content type="html">Six Flinders University Staff Make SA Science Excellence Awards Finals  </content>
    <updated>2012-08-06T04:39:09Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/142</id>
    <published>2012-08-06T04:39:09Z</published>
    <updated>2012-08-06T04:39:09Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/science-excellence-awards-finalists-announced"/>
    <url>http://bio-v2.katalyst.com.au/news_items/science-excellence-awards-finalists-announced</url>
    <title>Science Excellence Awards Finalists Announced</title>
    <content type="html">Science Excellence Awards Finalists Announced</content>
    <updated>2012-08-06T04:39:09Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/140</id>
    <published>2012-08-06T04:39:09Z</published>
    <updated>2012-08-06T04:39:09Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/tablets-you-take-without-any-food"/>
    <url>http://bio-v2.katalyst.com.au/news_items/tablets-you-take-without-any-food</url>
    <title>Tablets You Take Without Any Food</title>
    <content type="html">Tablets You Take Without Any Food</content>
    <updated>2012-08-06T04:39:09Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/141</id>
    <published>2012-08-06T04:39:09Z</published>
    <updated>2012-08-06T04:39:09Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/microalgae-bulging-with-biofuel-potential"/>
    <url>http://bio-v2.katalyst.com.au/news_items/microalgae-bulging-with-biofuel-potential</url>
    <title>Microalgae ‘Bulging with Biofuel Potential’</title>
    <content type="html">Microalgae ‘Bulging with Biofuel Potential’</content>
    <updated>2012-08-06T04:39:09Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/145</id>
    <published>2012-08-06T04:43:49Z</published>
    <updated>2012-08-06T04:43:49Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/world-s-first-fluorescent-flowers"/>
    <url>http://bio-v2.katalyst.com.au/news_items/world-s-first-fluorescent-flowers</url>
    <title>World's First Fluorescent Flowers</title>
    <content type="html">World's First Fluorescent Flowers</content>
    <updated>2012-08-06T04:43:49Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/146</id>
    <published>2012-08-06T04:43:49Z</published>
    <updated>2012-08-06T04:43:49Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/arc-linkage-grants-announced"/>
    <url>http://bio-v2.katalyst.com.au/news_items/arc-linkage-grants-announced</url>
    <title>ARC Linkage Grants Announced</title>
    <content type="html">ARC Linkage Grants Announced</content>
    <updated>2012-08-06T04:43:49Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/138</id>
    <published>2012-06-26T02:16:58Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/us-patent-granted-for-kv1-3-program"/>
    <url>http://bio-v2.katalyst.com.au/news_items/us-patent-granted-for-kv1-3-program</url>
    <title>US Patent Granted for KV1.3 Program</title>
    <content type="html">US Patent Granted for KV1.3 Program</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/136</id>
    <published>2012-06-25T06:13:18Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/mayne-clears-hurdle-to-subacap-approval-in-eu"/>
    <url>http://bio-v2.katalyst.com.au/news_items/mayne-clears-hurdle-to-subacap-approval-in-eu</url>
    <title>Mayne clears hurdle to SUBACAP approval in EU</title>
    <content type="html">Mayne clears hurdle to SUBACAP approval in EU</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/137</id>
    <published>2012-06-25T06:31:23Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/bio-2012-australian-biotechnology-s-time-to-shine"/>
    <url>http://bio-v2.katalyst.com.au/news_items/bio-2012-australian-biotechnology-s-time-to-shine</url>
    <title>BIO 2012: Australian biotechnology’s time to shine</title>
    <content type="html">BIO 2012: Australian biotechnology’s time to shine</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/134</id>
    <published>2012-06-25T05:50:03Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/what-the-raising-the-bar-research-exemption-means-for-biotech"/>
    <url>http://bio-v2.katalyst.com.au/news_items/what-the-raising-the-bar-research-exemption-means-for-biotech</url>
    <title>What the Raising the Bar research exemption means for biotech</title>
    <content type="html">What the Raising the Bar research exemption means for biotech</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/135</id>
    <published>2012-06-25T06:06:10Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/bionomics-to-expand-kv1-3-program"/>
    <url>http://bio-v2.katalyst.com.au/news_items/bionomics-to-expand-kv1-3-program</url>
    <title>Bionomics To Expand KV1.3 Program</title>
    <content type="html">Bionomics To Expand KV1.3 Program</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/133</id>
    <published>2012-06-04T07:58:18Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/2012-unsung-hero-awards-of-south-australian-science"/>
    <url>http://bio-v2.katalyst.com.au/news_items/2012-unsung-hero-awards-of-south-australian-science</url>
    <title>2012 Unsung Hero Awards of South Australian Science</title>
    <content type="html">2012 Unsung Hero Awards of South Australian Science</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/132</id>
    <published>2012-06-04T03:08:06Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/bionomics-launches-bnc105-ovarian-cancer-trial"/>
    <url>http://bio-v2.katalyst.com.au/news_items/bionomics-launches-bnc105-ovarian-cancer-trial</url>
    <title>Bionomics Launches BNC105 Ovarian Cancer Trial</title>
    <content type="html">Bionomics Launches BNC105 Ovarian Cancer Trial</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/131</id>
    <published>2012-06-04T02:27:58Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/new-biomarker-aims-at-affordable-bowel-cancer-test"/>
    <url>http://bio-v2.katalyst.com.au/news_items/new-biomarker-aims-at-affordable-bowel-cancer-test</url>
    <title>New Biomarker Aims at Affordable Bowel Cancer Test</title>
    <content type="html">New Biomarker Aims at Affordable Bowel Cancer Test</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/130</id>
    <published>2012-06-04T02:12:56Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/invest-in-research-says-visiting-chief-scientist"/>
    <url>http://bio-v2.katalyst.com.au/news_items/invest-in-research-says-visiting-chief-scientist</url>
    <title>Invest in research, says visiting Chief Scientist</title>
    <content type="html">Invest in Research, says visiting Chief Scientist</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/128</id>
    <published>2012-05-17T04:26:24Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/gene-patents-challenged-again"/>
    <url>http://bio-v2.katalyst.com.au/news_items/gene-patents-challenged-again</url>
    <title>Gene Patents Challenged Again</title>
    <content type="html">Gene Patents Challenged Again</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/126</id>
    <published>2012-05-17T04:12:51Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/sa-export-value-growth-continues-to-outpace-nation"/>
    <url>http://bio-v2.katalyst.com.au/news_items/sa-export-value-growth-continues-to-outpace-nation</url>
    <title>SA Export Value Growth Continues to Outpace Nation</title>
    <content type="html">SA Export Value Growth Continues to Outpace Nation</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/127</id>
    <published>2012-05-17T04:16:45Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/three-new-recruits-boost-unisa-s-itek-commercialisation-arm"/>
    <url>http://bio-v2.katalyst.com.au/news_items/three-new-recruits-boost-unisa-s-itek-commercialisation-arm</url>
    <title>Three New Recruits Boost UniSA's ITEK Commercialisation arm</title>
    <content type="html">Three New Recruits Boost UniSA's ITEK Commercialisation arm</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/129</id>
    <published>2012-05-17T23:46:56Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/ca-appoints-new-sa-case-managers"/>
    <url>http://bio-v2.katalyst.com.au/news_items/ca-appoints-new-sa-case-managers</url>
    <title>CA Appoints New SA Case Managers</title>
    <content type="html">CA Appoints New SA Case Managers</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/125</id>
    <published>2012-05-17T03:20:36Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/ausbiotech-reports-on-federal-budget"/>
    <url>http://bio-v2.katalyst.com.au/news_items/ausbiotech-reports-on-federal-budget</url>
    <title>AusBiotech Reports on Federal Budget</title>
    <content type="html">AusBiotech Reports on Federal Budget</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/123</id>
    <published>2012-05-03T01:42:13Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/cpi-rise-in-pharmaceuticals-due-to-pbs-safety-net"/>
    <url>http://bio-v2.katalyst.com.au/news_items/cpi-rise-in-pharmaceuticals-due-to-pbs-safety-net</url>
    <title>CPI Rise in Pharmaceuticals Due to PBS Safety Net</title>
    <content type="html">CPI Rise in Pharmaceuticals Due to PBS Safety Net</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/124</id>
    <published>2012-05-03T02:14:32Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/science-excellence-awards-sa-nominations"/>
    <url>http://bio-v2.katalyst.com.au/news_items/science-excellence-awards-sa-nominations</url>
    <title>Science Excellence Awards SA Nominations</title>
    <content type="html">Science Excellence Awards SA Nominations</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/122</id>
    <published>2012-05-03T01:34:46Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/ausbiotech-gsk-student-excellence-award-2012-nominations"/>
    <url>http://bio-v2.katalyst.com.au/news_items/ausbiotech-gsk-student-excellence-award-2012-nominations</url>
    <title>AusBiotech-GSK Student Excellence Award 2012 Nominations</title>
    <content type="html">AusBiotech-GSK Student Excellence Award 2012 Nominations</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/120</id>
    <published>2012-04-19T06:32:43Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/biotechnology-industry-position-survey-april-2012"/>
    <url>http://bio-v2.katalyst.com.au/news_items/biotechnology-industry-position-survey-april-2012</url>
    <title>Biotechnology Industry Position Survey April 2012</title>
    <content type="html">Biotechnology Industry Position Survey April 2012</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/121</id>
    <published>2012-04-19T06:54:58Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/flinders-university-medical-device-research-institute-officially-launched"/>
    <url>http://bio-v2.katalyst.com.au/news_items/flinders-university-medical-device-research-institute-officially-launched</url>
    <title>Flinders University Medical Device Research Institute Officially Launched</title>
    <content type="html">Flinders University Medical Device Research Institute Officially Launched</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/119</id>
    <published>2012-04-19T05:15:13Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/university-of-adelaide-omega-3-pioneer-honoured"/>
    <url>http://bio-v2.katalyst.com.au/news_items/university-of-adelaide-omega-3-pioneer-honoured</url>
    <title>University of Adelaide Omega-3 Pioneer Honoured</title>
    <content type="html">University of Adelaide Omega-3 pioneer honoured</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/118</id>
    <published>2012-04-19T02:09:06Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/sa-biotech-pioneer-recognised"/>
    <url>http://bio-v2.katalyst.com.au/news_items/sa-biotech-pioneer-recognised</url>
    <title>SA Biotech Pioneer Recognised</title>
    <content type="html">SA Biotech Pioneer Recognised</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/117</id>
    <published>2012-04-05T01:17:41Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/bnc105-ovarian-cancer-progress"/>
    <url>http://bio-v2.katalyst.com.au/news_items/bnc105-ovarian-cancer-progress</url>
    <title>BNC105 Ovarian Cancer Progress</title>
    <content type="html">Bionomics Limited (ASX: BNO) (ADR: BMICY) announced that it will present preclinical data showing the anti-cancer activity of BNC105 in platinum resistant ovarian cancer at the American Association for Cancer Research (AACR) Annual Meeting 2012 in Chicago, Illinois.</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/115</id>
    <published>2012-04-04T09:23:28Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/a-new-market-intelligence-tool-for-australian-researchers"/>
    <url>http://bio-v2.katalyst.com.au/news_items/a-new-market-intelligence-tool-for-australian-researchers</url>
    <title>A New Market Intelligence Tool for Australian Researchers</title>
    <content type="html">A New Market Intelligence Tool for Australian Researchers</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/105</id>
    <published>2012-03-21T00:05:55Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/start-early-to-reap-the-real-rewards"/>
    <url>http://bio-v2.katalyst.com.au/news_items/start-early-to-reap-the-real-rewards</url>
    <title>Start Early to Reap the Real Rewards</title>
    <content type="html">Start Early to Reap the Real Rewards</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/107</id>
    <published>2012-03-21T01:06:15Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/biospectrum-life-time-achievement-award-dr-john-ballard"/>
    <url>http://bio-v2.katalyst.com.au/news_items/biospectrum-life-time-achievement-award-dr-john-ballard</url>
    <title>BioSpectrum Life Time Achievement Award. Dr John Ballard</title>
    <content type="html">BioSpectrum Life Time Achievement Award. Dr John Ballard</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/112</id>
    <published>2012-03-21T04:33:58Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/lbt-lodges-international-patents-for-new-culture-plate-interpretation-technology"/>
    <url>http://bio-v2.katalyst.com.au/news_items/lbt-lodges-international-patents-for-new-culture-plate-interpretation-technology</url>
    <title>LBT Lodges International Patents for New Culture Plate Interpretation Technology</title>
    <content type="html">LBT Lodges International Patents for New Culture Plate Interpretation Technology</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/111</id>
    <published>2012-03-21T02:02:02Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/us-biotech-finds-chemistry-here"/>
    <url>http://bio-v2.katalyst.com.au/news_items/us-biotech-finds-chemistry-here</url>
    <title>US Biotech Finds Chemistry Here</title>
    <content type="html">US Biotech Finds Chemistry Here</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/109</id>
    <published>2012-03-21T01:40:37Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/world-breakthrough-on-salt-tolerant-wheat"/>
    <url>http://bio-v2.katalyst.com.au/news_items/world-breakthrough-on-salt-tolerant-wheat</url>
    <title>World Breakthrough on Salt-Tolerant Wheat</title>
    <content type="html">World Breakthrough on Salt-Tolerant Wheat</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/113</id>
    <published>2012-03-22T04:41:04Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/postpartum-trials-for-new-ultrasound-device"/>
    <url>http://bio-v2.katalyst.com.au/news_items/postpartum-trials-for-new-ultrasound-device</url>
    <title>Postpartum Trials for New Ultrasound Device</title>
    <content type="html">Postpartum Trials For New Ultrasound Device</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/101</id>
    <published>2012-03-07T03:46:25Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/anz-innovyz-start-entrepreneur-support-program-launched"/>
    <url>http://bio-v2.katalyst.com.au/news_items/anz-innovyz-start-entrepreneur-support-program-launched</url>
    <title>ANZ Innovyz START entrepreneur support program launched</title>
    <content type="html">ANZ Innovyz START entrepreneur support program launched</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/100</id>
    <published>2012-03-07T03:18:53Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/dupont-and-the-australian-centre-for-plant-functional-genomics"/>
    <url>http://bio-v2.katalyst.com.au/news_items/dupont-and-the-australian-centre-for-plant-functional-genomics</url>
    <title>DuPont and the Australian Centre for Plant Functional Genomics</title>
    <content type="html">DuPont and the Australian Centre for Plant Functional Genomics</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/104</id>
    <published>2012-03-08T01:03:42Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/intellectual-property-laws-and-patents"/>
    <url>http://bio-v2.katalyst.com.au/news_items/intellectual-property-laws-and-patents</url>
    <title>Intellectual Property Laws and Patents</title>
    <content type="html">Intellectual Property Laws and Patents</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/98</id>
    <published>2012-02-27T03:10:31Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/120-000-awarded-in-the-latest-round-of-aib-labs-research-infrastructure-funding"/>
    <url>http://bio-v2.katalyst.com.au/news_items/120-000-awarded-in-the-latest-round-of-aib-labs-research-infrastructure-funding</url>
    <title>$120,000 Awarded in the Latest Round of AIB Labs Research Infrastructure Funding</title>
    <content type="html">The latest round of the RIF program, specifically targeted to supporting ARC-LIEF applications, attracted four applications worth $350,000. Two successful applications were awarded a total amount of $120,000.</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/102</id>
    <published>2012-03-07T23:37:39Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/flinders-university-wins-seven-commercialisation-support-grants"/>
    <url>http://bio-v2.katalyst.com.au/news_items/flinders-university-wins-seven-commercialisation-support-grants</url>
    <title>Flinders University Wins Seven Commercialisation Support Grants</title>
    <content type="html">Flinders University Wins Seven Commercialisation Support Grants</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/103</id>
    <published>2012-03-07T23:54:29Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/entrepreneur-of-the-year-campaign-begins-for-2012"/>
    <url>http://bio-v2.katalyst.com.au/news_items/entrepreneur-of-the-year-campaign-begins-for-2012</url>
    <title>Entrepreneur of the Year Campaign Begins for 2012</title>
    <content type="html">Entrepreneur Of The Year campaign begins for 2012</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/93</id>
    <published>2012-02-22T23:58:42Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/bionomics-seeks-patent-for-alzheimer-s-treatment"/>
    <url>http://bio-v2.katalyst.com.au/news_items/bionomics-seeks-patent-for-alzheimer-s-treatment</url>
    <title>Bionomics Seeks Patent for Alzheimer's Treatment</title>
    <content type="html">Bionomics Seeks Patent for Alzheimer's Treatment</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/94</id>
    <published>2012-02-23T00:20:02Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/sardi-recruits-3-top-agricultural-scientists"/>
    <url>http://bio-v2.katalyst.com.au/news_items/sardi-recruits-3-top-agricultural-scientists</url>
    <title>SARDI Recruits 3 Top Agricultural Scientists</title>
    <content type="html">SARDI Recruits Three Top Agricultural Scientists</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/95</id>
    <published>2012-02-23T00:24:27Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/unisa-s-nanomaterials-expert-voelcker-wins-humboldt-fellowship"/>
    <url>http://bio-v2.katalyst.com.au/news_items/unisa-s-nanomaterials-expert-voelcker-wins-humboldt-fellowship</url>
    <title>UniSA’s Nanomaterials Expert Voelcker Wins Humboldt Fellowship</title>
    <content type="html">UniSA’s Nanomaterials Expert Voelcker Wins Humboldt Fellowship</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/97</id>
    <published>2012-02-23T00:39:00Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/bionomics-one-of-australia-s-best-performing-biotechs-in-the-past-year"/>
    <url>http://bio-v2.katalyst.com.au/news_items/bionomics-one-of-australia-s-best-performing-biotechs-in-the-past-year</url>
    <title>Bionomics One of Australia's Best-Performing Biotechs in the Past Year</title>
    <content type="html">Bionomics One of Australia's Best-Performing Biotechs in the Past Year</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/96</id>
    <published>2012-02-23T00:30:00Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/lbt-royalty-deal"/>
    <url>http://bio-v2.katalyst.com.au/news_items/lbt-royalty-deal</url>
    <title>LBT Royalty Deal</title>
    <content type="html">LBT Royalty Deal</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/84</id>
    <published>2012-02-08T23:00:34Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/biotechs-recover-from-slump-in-q2"/>
    <url>http://bio-v2.katalyst.com.au/news_items/biotechs-recover-from-slump-in-q2</url>
    <title>Biotechs Recover from Slump in Q2</title>
    <content type="html">Biotechs Recover from Slump in Q2</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/86</id>
    <published>2012-02-08T23:26:59Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/bnc105-renal-cancer-trial-data-presented-at-asco-gu"/>
    <url>http://bio-v2.katalyst.com.au/news_items/bnc105-renal-cancer-trial-data-presented-at-asco-gu</url>
    <title>BNC105 Renal Cancer Trial Data Presented at ASCO-GU</title>
    <content type="html">BNC105 Renal Cancer Trial Data Presented at ASCO-GU
</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/87</id>
    <published>2012-02-08T23:34:10Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/ausbiotech-submits-on-r-d-tax-incentive-discussion-paper"/>
    <url>http://bio-v2.katalyst.com.au/news_items/ausbiotech-submits-on-r-d-tax-incentive-discussion-paper</url>
    <title>AusBiotech Submits on R&amp;D Tax Incentive Discussion Paper </title>
    <content type="html">AusBiotech submits on R&amp;D Tax Incentive Discussion Paper 
</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/90</id>
    <published>2012-02-09T00:15:10Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/healthy-development-adelaide-hda-february-newsletter"/>
    <url>http://bio-v2.katalyst.com.au/news_items/healthy-development-adelaide-hda-february-newsletter</url>
    <title>Healthy Development Adelaide (HDA) February Newsletter</title>
    <content type="html">Healthy Development Adelaide (HDA) February Newsletter
</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/81</id>
    <published>2012-01-23T01:32:59Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/bench-to-bedside-research"/>
    <url>http://bio-v2.katalyst.com.au/news_items/bench-to-bedside-research</url>
    <title>Bench to Bedside Research</title>
    <content type="html">Bench to Bedside Research</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/92</id>
    <published>2012-02-09T00:22:19Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/australian-biotechs-attract-strong-interest-at-us-investor-meeting"/>
    <url>http://bio-v2.katalyst.com.au/news_items/australian-biotechs-attract-strong-interest-at-us-investor-meeting</url>
    <title>Australian Biotechs Attract Strong Interest at US Investor Meeting</title>
    <content type="html">Australian biotechs attract strong interest at US investor meeting
</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/80</id>
    <published>2012-01-22T23:40:19Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/flinders-research-develops-antibacterial-coating-for-desal-screens"/>
    <url>http://bio-v2.katalyst.com.au/news_items/flinders-research-develops-antibacterial-coating-for-desal-screens</url>
    <title>Flinders Research Develops Antibacterial Coating for Desal Screens</title>
    <content type="html">Flinders research develops antibacterial coating for desal screens
</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/83</id>
    <published>2012-01-25T00:18:34Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/chardonnay-genome-project-seeks-to-improve-wine"/>
    <url>http://bio-v2.katalyst.com.au/news_items/chardonnay-genome-project-seeks-to-improve-wine</url>
    <title>Chardonnay Genome Project Seeks to Improve Wine</title>
    <content type="html">Chardonnay genome project seeks to improve wine
</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/79</id>
    <published>2012-01-22T23:24:21Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/hospira-named-a-top-50-organization-for-multicultural-business-opportunities"/>
    <url>http://bio-v2.katalyst.com.au/news_items/hospira-named-a-top-50-organization-for-multicultural-business-opportunities</url>
    <title>Hospira Named a Top 50 Organization for Multicultural Business Opportunities</title>
    <content type="html">Hospira named a Top 50 Organization for Multicultural Business Opportunities</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/75</id>
    <published>2012-01-18T02:39:44Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/vivopharm-accesses-new-cancer-models-for-us-market"/>
    <url>http://bio-v2.katalyst.com.au/news_items/vivopharm-accesses-new-cancer-models-for-us-market</url>
    <title>vivoPharm Accesses New Cancer Models for US Market</title>
    <content type="html">vivoPharm Accesses New Cancer Models for US Market</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/91</id>
    <published>2012-02-09T00:20:16Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/industry-leaders-to-take-part-in-annual-industry-position-survey"/>
    <url>http://bio-v2.katalyst.com.au/news_items/industry-leaders-to-take-part-in-annual-industry-position-survey</url>
    <title>Industry Leaders to Take Part in Annual Industry Position Survey</title>
    <content type="html">Industry Leaders to Take Part in Annual Industry Position Survey</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/78</id>
    <published>2012-01-22T22:52:52Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/brett-sequencing-wins-awri-s-annual-innovation-award"/>
    <url>http://bio-v2.katalyst.com.au/news_items/brett-sequencing-wins-awri-s-annual-innovation-award</url>
    <title>Brett Sequencing Wins AWRI’s Annual Innovation Award</title>
    <content type="html">Brett sequencing wins AWRI’s annual Innovation Award</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/82</id>
    <published>2012-01-24T05:57:17Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/inspiring-australia-competitive-grant-round-now-open"/>
    <url>http://bio-v2.katalyst.com.au/news_items/inspiring-australia-competitive-grant-round-now-open</url>
    <title>Inspiring Australia competitive grant round now open!</title>
    <content type="html">Inspiring Australia competitive grant round now open!</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/74</id>
    <published>2012-01-12T02:41:10Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/future-looks-bright-for-biotech-firms"/>
    <url>http://bio-v2.katalyst.com.au/news_items/future-looks-bright-for-biotech-firms</url>
    <title>Future Looks Bright for Biotech Firms </title>
    <content type="html">Future looks bright for biotech firms </content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/72</id>
    <published>2012-01-11T23:11:41Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/ceo-update-and-us-investor-presentation"/>
    <url>http://bio-v2.katalyst.com.au/news_items/ceo-update-and-us-investor-presentation</url>
    <title>CEO Update and US Investor Presentation</title>
    <content type="html">CEO Update and US Investor Presentation</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/77</id>
    <published>2012-01-19T00:27:46Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/320-000-awarded-in-the-latest-round-of-aib-labs-research-infrastructure-funding"/>
    <url>http://bio-v2.katalyst.com.au/news_items/320-000-awarded-in-the-latest-round-of-aib-labs-research-infrastructure-funding</url>
    <title>$320,000 Awarded in the Latest Round of AIB Labs Research Infrastructure Funding</title>
    <content type="html">The latest round of AIB Labs Research Infrastructure Funding (RIF) resulted in the awarding of a total of $320,000, distributed between five successful applicants from Adelaide's three universities.</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/73</id>
    <published>2012-01-12T00:56:01Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/ironwood-pharmaceuticals-and-bionomics-announce-collaboration-research-and-license-agreement"/>
    <url>http://bio-v2.katalyst.com.au/news_items/ironwood-pharmaceuticals-and-bionomics-announce-collaboration-research-and-license-agreement</url>
    <title>Ironwood Pharmaceuticals and Bionomics Announce Collaboration, Research, and License Agreement </title>
    <content type="html">IRONWOOD PHARMACEUTICALS AND BIONOMICS ANNOUNCE
COLLABORATION, RESEARCH, AND LICENSE AGREEMENT</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/70</id>
    <published>2011-12-07T04:36:56Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/investing-in-innovative-companies"/>
    <url>http://bio-v2.katalyst.com.au/news_items/investing-in-innovative-companies</url>
    <title>Investing in Innovative Companies </title>
    <content type="html">INVESTING IN INNOVATIVE COMPANIES </content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/67</id>
    <published>2011-12-06T05:14:08Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/industry-thought-leaders-to-determine-policy-direction"/>
    <url>http://bio-v2.katalyst.com.au/news_items/industry-thought-leaders-to-determine-policy-direction</url>
    <title>Industry thought leaders to determine policy direction</title>
    <content type="html">Industry thought leaders to determine policy direction
</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/71</id>
    <published>2011-12-07T05:02:31Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/more-support-for-australian-innovators"/>
    <url>http://bio-v2.katalyst.com.au/news_items/more-support-for-australian-innovators</url>
    <title>More Support for Australian Innovators</title>
    <content type="html">Australian entrepreneurs will not have to repay Early Stage Commercialisation grants for businesses developing a new product, process, or service. Plus, these grants will be available to more businesses, as the annual turnover limit for applicants will rise from $20 million to $50 million. 

In addition, growing businesses that can benefit from access to skilled managers now have the option to apply for an Experienced Executives grant of up to $350,000 - up from $200,000. 

</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/65</id>
    <published>2011-12-06T05:02:34Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/r-d-tax-credit-regulations-registered-and-commenced"/>
    <url>http://bio-v2.katalyst.com.au/news_items/r-d-tax-credit-regulations-registered-and-commenced</url>
    <title>R &amp; D Tax Credit regulations registered and commenced</title>
    <content type="html">R and D Tax Credit regulations registered and commenced
</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/66</id>
    <published>2011-12-06T05:08:37Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/australia-s-top-researchers-honoured"/>
    <url>http://bio-v2.katalyst.com.au/news_items/australia-s-top-researchers-honoured</url>
    <title>Australia's top researchers honoured</title>
    <content type="html">Australia's top researchers honoured
</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/69</id>
    <published>2011-12-07T01:58:45Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/biomarin-announces-buyback-of-naglazyme-royalties-from-adelaide-health-authority"/>
    <url>http://bio-v2.katalyst.com.au/news_items/biomarin-announces-buyback-of-naglazyme-royalties-from-adelaide-health-authority</url>
    <title>BioMarin Announces Buyback of Naglazyme Royalties from Adelaide Health Authority </title>
    <content type="html">RSS ContentBioMarin Announces Buy Back of Naglazyme Royalties From Adelaide Health Authority 
</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/62</id>
    <published>2011-12-06T04:09:31Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/dna-barcoding-conference-comes-to-adelaide"/>
    <url>http://bio-v2.katalyst.com.au/news_items/dna-barcoding-conference-comes-to-adelaide</url>
    <title>DNA barcoding conference comes to Adelaide</title>
    <content type="html">More than 450 world experts from 60 countries will converge on Adelaide this week to discuss the importance of DNA "barcoding" - a rapidly growing international initiative to develop a genetic identity tool for all plants and animals on Earth.

The Fourth International Barcode of Life Conference will be held at the University of Adelaide from Wednesday 30 November to Saturday 3 December, with pre-conference workshops and other events on Monday and Tuesday 28-29 November.

</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/68</id>
    <published>2011-12-06T05:30:40Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/advancing-studies-in-minerals-processing-materials-nanoscience-with-multi-length-scale-3d-imaging"/>
    <url>http://bio-v2.katalyst.com.au/news_items/advancing-studies-in-minerals-processing-materials-nanoscience-with-multi-length-scale-3d-imaging</url>
    <title>Advancing Studies in Minerals Processing, Materials, Nanoscience With Multi-Length Scale 3D Imaging</title>
    <content type="html">Advancing Studies in Minerals Processing, Materials, Nanoscience With Multi-Length Scale 3D Imaging
</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/63</id>
    <published>2011-12-06T04:30:56Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/unisa-plays-key-role-in-national-flagship-automotive-and-environmental-research-centres"/>
    <url>http://bio-v2.katalyst.com.au/news_items/unisa-plays-key-role-in-national-flagship-automotive-and-environmental-research-centres</url>
    <title>UniSA plays key role in national flagship automotive and environmental research centres</title>
    <content type="html">Researchers at the University of South Australia are set to play a major role in building sustainable, innovative and efficient technologies as key contributors to two national Cooperative Research Centres (CRCs) announced this week.

The Federal Government funding announcement saw the foundation of a new CRC for Low Carbon Living, attracting $28 million and extended support for the AutoCRC with further funding of $26 million over the next five years.

</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/60</id>
    <published>2011-12-06T03:19:41Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/wine-researchers-sequence-brett-genome-in-world-first"/>
    <url>http://bio-v2.katalyst.com.au/news_items/wine-researchers-sequence-brett-genome-in-world-first</url>
    <title>Wine Researchers Sequence ‘Brett’ Genome in world first</title>
    <content type="html">Wine Researchers Sequence ‘Brett’ Genome in world first
</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/61</id>
    <published>2011-12-06T03:52:41Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/a-better-patent-system-to-secure-australia-s-prosperity"/>
    <url>http://bio-v2.katalyst.com.au/news_items/a-better-patent-system-to-secure-australia-s-prosperity</url>
    <title>A Better Patent System to Secure Australia's Prosperity </title>
    <content type="html">Providing patent protection for innovators and researchers – while ensuring reasonable access to new technologies and medical treatments – are the key aims of the Government’s response to three important reports into Australia’s patent system and gene patents.

Minister for Innovation Senator Kim Carr acknowledged concerns in the community about gene patents and said the Gillard Labor Government carefully considered reports from a Senate Committee, the Advisory Council on Intellectual Property and the Australian Law Reform Commission in preparing its response.

</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/59</id>
    <published>2011-11-22T03:32:07Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/national-recognition-for-medical-device-collaboration"/>
    <url>http://bio-v2.katalyst.com.au/news_items/national-recognition-for-medical-device-collaboration</url>
    <title>National recognition for medical device collaboration</title>
    <content type="html">Flinders Medical Device scheme 'best collaboration in Australia'
</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/58</id>
    <published>2011-11-15T00:36:32Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/bnc210-anti-anxiety-clinical-data-presented-at-neuroscience-2011"/>
    <url>http://bio-v2.katalyst.com.au/news_items/bnc210-anti-anxiety-clinical-data-presented-at-neuroscience-2011</url>
    <title>BNC210 anti-anxiety clinical data presented at Neuroscience 2011</title>
    <content type="html">Tuesday, 15th November 2011: Bionomics Limited (ASX:BNO) is pleased to announce that the
successful Phase Ib panic attack trial results reported on March 30 this year will be presented at the
annual Society For Neuroscience conference, Neuroscience 2011 in Washington DC today.</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/55</id>
    <published>2011-11-08T00:12:14Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/science-excellence-award-winners"/>
    <url>http://bio-v2.katalyst.com.au/news_items/science-excellence-award-winners</url>
    <title>Science Excellence Award Winners</title>
    <content type="html">Science Excellence Awards Winners</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/56</id>
    <published>2011-11-08T00:27:39Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/south-australian-of-the-year-health-category-award-winner"/>
    <url>http://bio-v2.katalyst.com.au/news_items/south-australian-of-the-year-health-category-award-winner</url>
    <title>South Australian of the Year Health Category Award Winner</title>
    <content type="html">South Australian of the Year Health Category Award Winner</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/57</id>
    <published>2011-11-08T02:30:24Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/ceridia-wins-48-000-commercialisation-grant"/>
    <url>http://bio-v2.katalyst.com.au/news_items/ceridia-wins-48-000-commercialisation-grant</url>
    <title>Ceridia wins $48,000 commercialisation grant </title>
    <content type="html">Ceridia wins $48,000 commercialisation grant </content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/54</id>
    <published>2011-11-07T23:48:15Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/australian-research-council-s-major-grant-schemes"/>
    <url>http://bio-v2.katalyst.com.au/news_items/australian-research-council-s-major-grant-schemes</url>
    <title>Australian Research Council's major grant schemes</title>
    <content type="html">Australian Research Council's major grant schemes</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/52</id>
    <published>2011-10-24T04:31:54Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/donaldson-walsh-lawyers-all-new-website"/>
    <url>http://bio-v2.katalyst.com.au/news_items/donaldson-walsh-lawyers-all-new-website</url>
    <title>Donaldson Walsh Lawyers all-new website</title>
    <content type="html">Donalson Walsh Lawyers all-new website</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/51</id>
    <published>2011-10-24T03:41:11Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/tr35-singapore"/>
    <url>http://bio-v2.katalyst.com.au/news_items/tr35-singapore</url>
    <title>TR35 @Singapore</title>
    <content type="html">Massachusetts Institute of Technology's (MIT) Technology Review invites nominations for the inaugural TR35@SingaporeAwards.</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/53</id>
    <published>2011-10-25T04:02:29Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/biosa-at-ausbiotech-2011"/>
    <url>http://bio-v2.katalyst.com.au/news_items/biosa-at-ausbiotech-2011</url>
    <title>BioSA at AusBiotech 2011</title>
    <content type="html">BioSA at AusBiotech 2011</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/50</id>
    <published>2011-10-05T02:54:52Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/health-development-adelaide-hda-october-newsletter"/>
    <url>http://bio-v2.katalyst.com.au/news_items/health-development-adelaide-hda-october-newsletter</url>
    <title>Health Development Adelaide (HDA) October Newsletter</title>
    <content type="html">Healthy Development Adelaide (HDA) Travel Grants and HDA &amp; Channel 7 Scholarships are open for applications
HDA will provide up to 10 travel grants for final year PhD students and Early Career Researchers (up to 5 years post PhD) to further their research career by attending and presenting at international conference in 2012. Applications close 8 December 2011.

HDA and Channel 7 Children’s Research Foundation (top-up) PhD Scholarships are inviting applications for ‘multidisciplinary’ PhD Research Scholarships in the areas of Healthy Development: Applications are invited from domestic and international students who are commencing a PhD. Applications close 1 November 2011.

</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/49</id>
    <published>2011-09-27T04:50:07Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/vivopharm-announces-new-chairman-of-the-board"/>
    <url>http://bio-v2.katalyst.com.au/news_items/vivopharm-announces-new-chairman-of-the-board</url>
    <title>vivoPharm announces new Chairman of the Board</title>
    <content type="html">vivoPharm Pty Ltd is pleased to announce that Ian Nisbet, PhD, MAICD has joined its Board of Directors and has been appointed as the new Chairman of the Board.</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/46</id>
    <published>2011-09-21T23:28:23Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/bcn105-renal-cancel-trial-update"/>
    <url>http://bio-v2.katalyst.com.au/news_items/bcn105-renal-cancel-trial-update</url>
    <title>BCN105 Renal Cancel Trial Update</title>
    <content type="html">20 September 2011; Adelaide, Australia:Bionomics Limited (ASX: BNO; ADR: BMICY) provides an update on the ongoing US clinical trial of BNC105, its proprietary vascular disrupting agent (VDA) in patients with metastatic renal cell cancer (RCC) of the kidney.</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/48</id>
    <published>2011-09-26T04:05:09Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/south-australian-company-furthers-treatment-for-heart-disease"/>
    <url>http://bio-v2.katalyst.com.au/news_items/south-australian-company-furthers-treatment-for-heart-disease</url>
    <title>South Australian company furthers treatment for heart disease</title>
    <content type="html">Clinical trial of vessel dilator for congestive heart failure (CHF) patients</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/43</id>
    <published>2011-09-19T04:22:06Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/bionomics-unveils-new-drug"/>
    <url>http://bio-v2.katalyst.com.au/news_items/bionomics-unveils-new-drug</url>
    <title>Bionomics Unveils New Drug</title>
    <content type="html">BIONOMICS’ anti-anxiety compound BNC210 was presented for the first time at the 24th annual European College of Neuropsychopharmacology conference this week.
</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/44</id>
    <published>2011-09-19T05:01:57Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/latest-bnc210-data-presented-at-major-international-conference"/>
    <url>http://bio-v2.katalyst.com.au/news_items/latest-bnc210-data-presented-at-major-international-conference</url>
    <title>Latest BNC210 Data Presented at Major International Conference</title>
    <content type="html">Latest BNC210 Data Presented at Major International Conference</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/45</id>
    <published>2011-09-19T05:08:22Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/vivopharm-announces-strategic-alliance-with-mpi-research"/>
    <url>http://bio-v2.katalyst.com.au/news_items/vivopharm-announces-strategic-alliance-with-mpi-research</url>
    <title>vivoPharm Announces Strategic Alliance with MPI Research</title>
    <content type="html">vivoPharm Announces Strategic Alliance with MPI Research</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/42</id>
    <published>2011-08-11T06:22:33Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/2011-south-australian-science-excellence-awards-call-for-nominations"/>
    <url>http://bio-v2.katalyst.com.au/news_items/2011-south-australian-science-excellence-awards-call-for-nominations</url>
    <title>2011 South Australian Science Excellence Awards - Call for nominations</title>
    <content type="html">NOMINATIONS OPEN 11 AUGUST FOR SOUTH AUSTRALIAN SCIENCE EXCELLENCE AWARDS

Nominations for the South Australian Science Excellence Awards are called from the business community for recent PhD graduates and early career science, technology, engineering and mathematics professionals, with no more than five years workforce experience. Nominations Close 9 September 2011. Click here for more information.
</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/39</id>
    <published>2011-08-09T00:05:48Z</published>
    <updated>2012-07-02T04:28:27Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/bnc105-cancer-clinical-trials-reach-key-milestones-clinical-program-to-be-expanded"/>
    <url>http://bio-v2.katalyst.com.au/news_items/bnc105-cancer-clinical-trials-reach-key-milestones-clinical-program-to-be-expanded</url>
    <title>BNC105 Cancer Clinical Trials Reach Key Milestones Clinical Program to be Expanded</title>
    <content type="html">BNC105 CANCER CLINICAL TRIALS REACH KEY MILESTONES
CLINICAL PROGRAM TO BE EXPANDED</content>
    <updated>2012-07-02T04:28:27Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/40</id>
    <published>2011-08-09T02:15:34Z</published>
    <updated>2012-07-02T04:28:28Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/healthy-development-adelaide-hda-august-newsletter"/>
    <url>http://bio-v2.katalyst.com.au/news_items/healthy-development-adelaide-hda-august-newsletter</url>
    <title>Healthy Development Adelaide (HDA) August Newsletter</title>
    <content type="html">Healthy Development Adelaide (HDA) August Newsletter</content>
    <updated>2012-07-02T04:28:28Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/38</id>
    <published>2011-08-08T06:39:19Z</published>
    <updated>2012-07-02T04:28:28Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/university-of-south-australia-appoints-head-of-australian-wine-research-institute-as-deputy-vice-chancellor"/>
    <url>http://bio-v2.katalyst.com.au/news_items/university-of-south-australia-appoints-head-of-australian-wine-research-institute-as-deputy-vice-chancellor</url>
    <title>University of South Australia appoints head of Australian Wine Research Institute as Deputy Vice Chancellor</title>
    <content type="html">University of South Australia appoints head of Australian Wine Research Institute as Deputy Vice Chancellor</content>
    <updated>2012-07-02T04:28:28Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/41</id>
    <published>2011-08-09T06:18:18Z</published>
    <updated>2012-07-02T04:28:28Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/australian-biotech-ceridia-pty-ltd-completes-successful-human-clinical-trial"/>
    <url>http://bio-v2.katalyst.com.au/news_items/australian-biotech-ceridia-pty-ltd-completes-successful-human-clinical-trial</url>
    <title>Australian Biotech Ceridia Pty Ltd Completes Successful Human Clinical Trial</title>
    <content type="html">ADELAIDE, Australia, July 26, 2011 /PRNewswire/ -- Ceridia Pty Ltd., a biotechnology company focused on reformulating and developing therapeutic drugs, announce the successful completion of Phase 1 Proof-of-Concept study of its novel LipoCeramic ibuprofen formulation, CER006. </content>
    <updated>2012-07-02T04:28:28Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/37</id>
    <published>2011-07-22T03:31:23Z</published>
    <updated>2012-07-02T04:28:28Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/biosa-releases-2011-strategy-for-biosciences-growth"/>
    <url>http://bio-v2.katalyst.com.au/news_items/biosa-releases-2011-strategy-for-biosciences-growth</url>
    <title>BioSA Releases 2011 Strategy for Biosciences Growth</title>
    <content type="html">To coincide with its 10-year anniversary, BioSA will launch a strategy aimed at building the South Australian biotechnology sector into a major centre for bioscience business in the Asia Pacific region. During its 10 successful years in operation, BioSA has generated over $150 million in new benefits to the state.</content>
    <updated>2012-07-02T04:28:28Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/34</id>
    <published>2011-07-07T02:59:46Z</published>
    <updated>2012-07-02T04:28:28Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/sequencing-the-tasmanian-devil-genome-a-species-under-threat"/>
    <url>http://bio-v2.katalyst.com.au/news_items/sequencing-the-tasmanian-devil-genome-a-species-under-threat</url>
    <title>Sequencing the Tasmanian Devil Genome - A Species Under Threat</title>
    <content type="html">GeneWorks has played an important role in a collaborative project to sequence and analyse the genome of the Tasmanian Devil. The Australian marsupial is at risk of extinction due to an infectious transmissible facial cancer. </content>
    <updated>2012-07-02T04:28:28Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/36</id>
    <published>2011-07-07T03:46:41Z</published>
    <updated>2012-07-02T04:28:28Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/acpfg-helps-lead-australian-french-push-for-international-wheat-research-initiative"/>
    <url>http://bio-v2.katalyst.com.au/news_items/acpfg-helps-lead-australian-french-push-for-international-wheat-research-initiative</url>
    <title>ACPFG Helps Lead Australian / French Push for International Wheat Research Initiative</title>
    <content type="html">G20 Agriculture Ministers in Paris have approved the establishment of a new International Research Initiative for Wheat Improvement.  Dr Hélène Lucas from the Institut National de la Recherche Agronomique (INRA) and Professor Peter Langridge from the Australian Centre for Plant Functional Genomics (ACPFG) presented the proposal to the G20 Agriculture deputies on the 12th May 2011. The historic agreement was reached by the Ag Ministers on 23rd June 2011.</content>
    <updated>2012-07-02T04:28:28Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/35</id>
    <published>2011-07-07T03:39:58Z</published>
    <updated>2012-07-02T04:28:28Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/vaxine-awarded-vaccine-industry-excellence-award"/>
    <url>http://bio-v2.katalyst.com.au/news_items/vaxine-awarded-vaccine-industry-excellence-award</url>
    <title>Vaxine Awarded Vaccine Industry Excellence Award</title>
    <content type="html">Vaxine has received the prestigious Vaccine Industry Excellence (VIE) Award for the Most Innovative Asian Biotech. Presented at the 2011 Annual World Vaccine Congress Asia (20-24 June, Singapore), the awards recognise and celebrate the leaders, innovators and pioneers in the Asian vaccines industry.</content>
    <updated>2012-07-02T04:28:28Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/32</id>
    <published>2011-06-23T00:28:17Z</published>
    <updated>2012-07-02T04:28:28Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/phase-i-bnc105-clinical-trial-published"/>
    <url>http://bio-v2.katalyst.com.au/news_items/phase-i-bnc105-clinical-trial-published</url>
    <title>Phase I BNC105 Clinical Trial Published</title>
    <content type="html">Bionomics Limited (ASX:BNO; ADR:BMCY) has announced the publication of the Phase I clinical trial data in the peer-reviewed, international journal Clinical Cancer Research, a journal of the American Association for Cancer Research.  </content>
    <updated>2012-07-02T04:28:28Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/31</id>
    <published>2011-06-20T03:47:49Z</published>
    <updated>2012-07-02T04:28:28Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/merck-serono-extends-multiple-sclerosis-collaboration-with-bionomics"/>
    <url>http://bio-v2.katalyst.com.au/news_items/merck-serono-extends-multiple-sclerosis-collaboration-with-bionomics</url>
    <title>Merck Serono Extends Multiple Sclerosis Collaboration with Bionomics</title>
    <content type="html">MERCK SERONO EXTENDS MULTIPLE SCLEROSIS COLLABORATION WITH BIONOMICS</content>
    <updated>2012-07-02T04:28:28Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/30</id>
    <published>2011-05-25T00:53:31Z</published>
    <updated>2012-07-02T04:28:28Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/276-new-jobs-for-south-australians"/>
    <url>http://bio-v2.katalyst.com.au/news_items/276-new-jobs-for-south-australians</url>
    <title>276 New Jobs for South Australians</title>
    <content type="html">More than 270 new jobs are being created in South Australia thanks to the Gillard and Rann Labor governments.

Announcing $6.1 million for 11 South Australian companies under the South Australia Innovation and Investment Fund, Federal Innovation Minister Senator Kim Carr and South Australian Industry Minister Tom Koutsantonis highlighted the importance of manufacturing to the local economy.</content>
    <updated>2012-07-02T04:28:28Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/29</id>
    <published>2011-05-24T07:16:40Z</published>
    <updated>2012-07-02T04:28:28Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/independent-study-provides-further-validation-of-bnc210-following-recent-success-of-phase-ib-trials"/>
    <url>http://bio-v2.katalyst.com.au/news_items/independent-study-provides-further-validation-of-bnc210-following-recent-success-of-phase-ib-trials</url>
    <title>Independent study provides further validation of BNC210 following recent success of phase Ib trials</title>
    <content type="html">INDEPENDENT STUDY PROVIDES FURTHER VALIDATION OF BNC210 FOLLOWING RECENT SUCCESS OF PHASE Ib TRIALS</content>
    <updated>2012-07-02T04:28:28Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/28</id>
    <published>2011-05-04T15:46:18Z</published>
    <updated>2012-07-02T04:28:28Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/bionomics-sells-thebarton-premises-to-substantially-boost-cash-reserves"/>
    <url>http://bio-v2.katalyst.com.au/news_items/bionomics-sells-thebarton-premises-to-substantially-boost-cash-reserves</url>
    <title>Bionomics Sells Thebarton Premises to Substantially Boost Cash Reserves</title>
    <content type="html">4 May 2011, Adelaide, Australia: Bionomics Limited (ASX: BNO; ADR: BMICY) has entered into a contract to sell its head office and research facility in Thebarton, South Australia. </content>
    <updated>2012-07-02T04:28:28Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/27</id>
    <published>2011-04-06T17:33:31Z</published>
    <updated>2012-07-02T04:28:28Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/bionomics-limited-broadcast"/>
    <url>http://bio-v2.katalyst.com.au/news_items/bionomics-limited-broadcast</url>
    <title>Bionomics Limited Broadcast</title>
    <content type="html">BIONOMICS LIMITED (BNO) provides the opportunity to listen to an audio broadcast with Dr Deborah
Rathjen, Managing Director and CEO in a presentation titled "Bionomics Anti-Anxiety Drug Clinical
Trials Successful Results - Dr Deborah Rathjen, Managing Director &amp; CEO".</content>
    <updated>2012-07-02T04:28:28Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/26</id>
    <published>2011-04-01T13:23:07Z</published>
    <updated>2012-07-02T04:28:28Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/bnc105-data-presented-at-aacr-conference"/>
    <url>http://bio-v2.katalyst.com.au/news_items/bnc105-data-presented-at-aacr-conference</url>
    <title>BNC105 Data Presented at AACR Conference</title>
    <content type="html">Bionomics Limited (ASX:BNO; ADR:BMICY) today announced that its leading vascular disrupting agent (VDA), BNC105,  would be the subject of two poster presentations at the prestigious annual American Association for Cancer Research (AACR) conference in Orlando, USA.</content>
    <updated>2012-07-02T04:28:28Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/25</id>
    <published>2011-04-01T11:22:00Z</published>
    <updated>2012-07-02T04:28:28Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/surgeons-announce-new-advance-for-sinus-sufferers"/>
    <url>http://bio-v2.katalyst.com.au/news_items/surgeons-announce-new-advance-for-sinus-sufferers</url>
    <title>Surgeons Announce New Advance for Sinus Sufferers</title>
    <content type="html">Sinus sufferers around the world could benefit from a new gel co-developed by the University of Adelaide, which prevents scarring after surgery.

</content>
    <updated>2012-07-02T04:28:28Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/24</id>
    <published>2011-03-31T11:04:07Z</published>
    <updated>2012-07-02T04:28:28Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/bionomics-anti-anxiety-drug-phase-ib-clinical-trials-successful-results"/>
    <url>http://bio-v2.katalyst.com.au/news_items/bionomics-anti-anxiety-drug-phase-ib-clinical-trials-successful-results</url>
    <title>Bionomics Anti-Anxiety Drug Phase Ib Clinical Trials Successful Results</title>
    <content type="html">Bionomics Limited (ASX: BNO) (ADR: BMICY) has successfully concluded two Phase Ib clinical trials of BNC210 which is being developed as a new generation treatment for anxiety and depression.</content>
    <updated>2012-07-02T04:28:28Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/23</id>
    <published>2011-03-15T17:13:59Z</published>
    <updated>2012-07-02T04:28:28Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/inaugural-marine-biotechnology-seminar-marine-biodiversity-positioning-sa"/>
    <url>http://bio-v2.katalyst.com.au/news_items/inaugural-marine-biotechnology-seminar-marine-biodiversity-positioning-sa</url>
    <title>Inaugural Marine Biotechnology Seminar - Marine Biodiversity: Positioning SA</title>
    <content type="html">The inaugural Flinders University Marine Biotechnology Seminar, co-sponsored by BioSA seeks to pioneer in South Australia the engagement of industry in Marine Diversity, a biotechnology field with industry-transforming technologies and high-value products. Come and hear Professor Joe Baker, one of the founding members in marine biotechnology research in Australia and a former director of the Australian Institute of Marine Science (AIMS) in Queensland, share his experience and vision for the potential of this field for education and industry. </content>
    <updated>2012-07-02T04:28:28Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/22</id>
    <published>2011-03-04T11:14:02Z</published>
    <updated>2012-07-02T04:28:28Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/austofix-enters-into-new-commercial-arrangement-with-australia-s-largest-provider-of-private-orthopaedic-surgery"/>
    <url>http://bio-v2.katalyst.com.au/news_items/austofix-enters-into-new-commercial-arrangement-with-australia-s-largest-provider-of-private-orthopaedic-surgery</url>
    <title>Austofix enters into new commercial arrangement with Australia’s largest provider of private orthopaedic surgery</title>
    <content type="html">Adelaide-based orthopaedic implant manufacturer, Austofix (ASX:AYX) has entered into a commercial arrangement with Ortho Group Pty Ltd (OGL), an arrangement that will enable Austofix to work with, and market its products to, some of the country’s leading orthopaedic surgeons.</content>
    <updated>2012-07-02T04:28:28Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/21</id>
    <published>2011-02-17T11:03:49Z</published>
    <updated>2012-07-02T04:28:28Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/bio-innovation-sa-makes-new-appointment"/>
    <url>http://bio-v2.katalyst.com.au/news_items/bio-innovation-sa-makes-new-appointment</url>
    <title>BioSA Makes New Appointment</title>
    <content type="html">BioSA (BioSA) has appointed Dr Stephen Rodda to the position of Business Development Director replacing Mr Neil Finlayson. </content>
    <updated>2012-07-02T04:28:28Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/139</id>
    <published>2012-08-06T04:39:09Z</published>
    <updated>2012-08-06T04:39:09Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/bio-innovation-sa-makes-new-appointment--2"/>
    <url>http://bio-v2.katalyst.com.au/news_items/bio-innovation-sa-makes-new-appointment--2</url>
    <title>Bio Innovation SA Makes New Appointment</title>
    <content type="html">Bio Innovation SA (BioSA) has appointed Dr Stephen Rodda to the position of Business Development Director replacing Mr Neil Finlayson. </content>
    <updated>2012-08-06T04:39:09Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/19</id>
    <published>2011-02-10T10:58:03Z</published>
    <updated>2012-07-02T04:28:28Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/patent-to-be-granted-for-salinity-tolerance-technology"/>
    <url>http://bio-v2.katalyst.com.au/news_items/patent-to-be-granted-for-salinity-tolerance-technology</url>
    <title>Patent to be granted for salinity tolerance technology</title>
    <content type="html">The Australian Centre for Plant Functional Genomics’ first patent application has been accepted for grant in Eurasia.  The patent covers salinity tolerance in plants and applies in Turkmenistan, Belarus, Tajikistan, Russia, Azerbaijan, Kazakhstan, Kyrgyzstan, Armenia and the Moldova regions.</content>
    <updated>2012-07-02T04:28:28Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/20</id>
    <published>2011-02-10T11:01:23Z</published>
    <updated>2012-07-02T04:28:28Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/bnc105-data-presented-at-lorne-cancer-conference"/>
    <url>http://bio-v2.katalyst.com.au/news_items/bnc105-data-presented-at-lorne-cancer-conference</url>
    <title>BNC105 Data Presented at Lorne Cancer Conference</title>
    <content type="html">Bionomics Limited (ASX:BNO; ADR:BMICY) today announced that BNC105 would be the subject of three poster presentations at the 23rd Lorne Cancer Conference, Victoria Australia.</content>
    <updated>2012-07-02T04:28:28Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/18</id>
    <published>2011-02-04T10:53:40Z</published>
    <updated>2012-07-02T04:28:28Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/patent-applications-filed-on-compounds-to-treat-memory-loss"/>
    <url>http://bio-v2.katalyst.com.au/news_items/patent-applications-filed-on-compounds-to-treat-memory-loss</url>
    <title>Patent Applications Filed on Compounds to Treat Memory Loss</title>
    <content type="html">Bionomics Limited (ASX:BNO; ADR:BMICY) today announced the filing of two patent applications covering compounds that are activators of the alpha7 nicotinic acetylcholine receptor.
</content>
    <updated>2012-07-02T04:28:28Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/16</id>
    <published>2011-02-01T10:05:52Z</published>
    <updated>2012-07-02T04:28:28Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/healthy-development-adelaide-hda-newsletter"/>
    <url>http://bio-v2.katalyst.com.au/news_items/healthy-development-adelaide-hda-newsletter</url>
    <title>Healthy Development Adelaide (HDA) Newsletter</title>
    <content type="html">HDA member receives Australia Day Honours</content>
    <updated>2012-07-02T04:28:28Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/17</id>
    <published>2011-02-01T14:03:41Z</published>
    <updated>2012-07-02T04:28:28Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/asx-announcement-open-briefing-ceo-on-bnc-clinical-trials-and-cash-position"/>
    <url>http://bio-v2.katalyst.com.au/news_items/asx-announcement-open-briefing-ceo-on-bnc-clinical-trials-and-cash-position</url>
    <title>ASX Announcement - Open Briefing "CEO on BNC Clinical Trials and Cash Position"</title>
    <content type="html">Open Briefing titled "CEO on BNC Clinical Trials and Cash Position" lodged with the ASX today.</content>
    <updated>2012-07-02T04:28:28Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/15</id>
    <published>2011-01-28T10:26:24Z</published>
    <updated>2012-07-02T04:28:28Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/mike-hirshorn-joins-lbt-innovations-board"/>
    <url>http://bio-v2.katalyst.com.au/news_items/mike-hirshorn-joins-lbt-innovations-board</url>
    <title>Mike Hirshorn joins LBT Innovations board</title>
    <content type="html">Adelaide-based clinical and diagnostic technology company, LBT Innovations Limited (ASX:LBT) today announced that biotech industry veteran, Mike Hirshorn, will join the company as non-executive director.</content>
    <updated>2012-07-02T04:28:28Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/13</id>
    <published>2011-01-13T12:43:56Z</published>
    <updated>2012-07-02T04:28:28Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/ceo-update-and-us-investor-presentation"/>
    <url>http://bio-v2.katalyst.com.au/news_items/ceo-update-and-us-investor-presentation</url>
    <title>CEO Update and US Investor Presentation</title>
    <content type="html">Bionomics Limited (ASX:BNO) today announced its CEO, Dr Deborah Rathjen, will present a company update at the Biotech Showcase 2011 in San Francisco, USA.
</content>
    <updated>2012-07-02T04:28:28Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/14</id>
    <published>2011-01-13T13:01:09Z</published>
    <updated>2012-07-02T04:28:28Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/adelaide-ivf-breakthrough-to-hit-the-world-market"/>
    <url>http://bio-v2.katalyst.com.au/news_items/adelaide-ivf-breakthrough-to-hit-the-world-market</url>
    <title>Adelaide IVF breakthrough to hit the world market</title>
    <content type="html">A University of Adelaide reproductive biologist has achieved a major breakthrough in IVF technology that is expected to help millions of women around the world who have suffered previous miscarriages after IVF treatment.

Professor Sarah Robertson, an NHMRC Principal Research Fellow and member of the University's Robinson Institute, has partnered with a Danish company to develop a product which improves IVF embryo implantation rates for some women by up to 40%.
</content>
    <updated>2012-07-02T04:28:28Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/12</id>
    <published>2010-12-17T10:46:14Z</published>
    <updated>2012-07-02T04:28:28Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/bionomics-now-december-newsletter"/>
    <url>http://bio-v2.katalyst.com.au/news_items/bionomics-now-december-newsletter</url>
    <title>Bionomics NOW December Newsletter</title>
    <content type="html">The BNC210 clinical program has progressed
rapidly and productively in a very short space of
time.</content>
    <updated>2012-07-02T04:28:28Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/10</id>
    <published>2010-12-14T12:12:27Z</published>
    <updated>2012-07-02T04:28:28Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/turning-waste-into-a-valuable-green-commodity"/>
    <url>http://bio-v2.katalyst.com.au/news_items/turning-waste-into-a-valuable-green-commodity</url>
    <title>Turning waste into a valuable ‘green’ commodity</title>
    <content type="html">New technology developed by South Australian scientists has shown how intensive Australian farming and food processing systems can save water, turn waste into a profitable resource and prevent pollution.</content>
    <updated>2012-07-02T04:28:28Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/11</id>
    <published>2010-12-16T09:58:55Z</published>
    <updated>2012-07-02T04:28:28Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/tgr-biosciences-announces-distribution-partnership-with-cedarlane-corporation"/>
    <url>http://bio-v2.katalyst.com.au/news_items/tgr-biosciences-announces-distribution-partnership-with-cedarlane-corporation</url>
    <title>TGR BioSciences Announces Distribution Partnership with Cedarlane Corporation</title>
    <content type="html">ADELAIDE, Australia--(BUSINESS WIRE)--TGR BioSciences, a leading global provider of advanced cell based assay technologies in the fields of cancer, kinase and GPCR research, is extremely pleased to announce a distribution partnership with Cedarlane Laboratories of Burlington, ON, Canada, a leading supplier of Life Science research reagents in North America</content>
    <updated>2012-07-02T04:28:28Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/9</id>
    <published>2010-12-09T16:36:22Z</published>
    <updated>2012-07-02T04:28:28Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/lbt-shareholders-news"/>
    <url>http://bio-v2.katalyst.com.au/news_items/lbt-shareholders-news</url>
    <title>LBT Shareholders News</title>
    <content type="html">By now many of you have seen the various presentations posted on the ASX
platform after the AGM on 15 November. However, it is realised that there was much information to read and the company is keen to draw your attention in this newsletter to some of the key points that came out of the meeting.</content>
    <updated>2012-07-02T04:28:28Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/3</id>
    <published>2010-11-30T14:15:59Z</published>
    <updated>2012-07-02T04:28:28Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/us-1-3m-expansion-opens-us-markets-to-vivopharm"/>
    <url>http://bio-v2.katalyst.com.au/news_items/us-1-3m-expansion-opens-us-markets-to-vivopharm</url>
    <title>US$1.3M expansion opens US markets to vivoPharm</title>
    <content type="html">Adelaide-based contract research organisation vivoPharm Pty Ltd is set to expand its global reach after securing US$1.3 million in funding and support to establish its operations in the United States.</content>
    <updated>2012-07-02T04:28:28Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/7</id>
    <published>2010-12-06T09:10:31Z</published>
    <updated>2012-07-02T04:28:28Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/du-pont-and-the-australian-centre-for-plant-functional-genomics-extend-partnership-to-increase-agricultural-productivity"/>
    <url>http://bio-v2.katalyst.com.au/news_items/du-pont-and-the-australian-centre-for-plant-functional-genomics-extend-partnership-to-increase-agricultural-productivity</url>
    <title>Du Pont and the Australian Centre for Plant Functional Genomics Extend Partnership to Increase Agricultural Productivity</title>
    <content type="html">DuPont and the Australian Centre for Plant Functional Genomics (ACPFG) announce that they have extended thier long-standing research collaboration and commitment to increasing productivity in leading production crops.</content>
    <updated>2012-07-02T04:28:28Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
  <entry>
    <id>tag:bio-v2.katalyst.com.au,2005:BusinessNews/8</id>
    <published>2010-12-06T09:14:22Z</published>
    <updated>2012-07-02T04:28:28Z</updated>
    <link rel="alternate" type="text/html" href="http://bio-v2.katalyst.com.au/business_news/latest-bnc210-anxiety-drug-data-to-be-presented-at-us-neuroscience-conference"/>
    <url>http://bio-v2.katalyst.com.au/news_items/latest-bnc210-anxiety-drug-data-to-be-presented-at-us-neuroscience-conference</url>
    <title>Latest BNC210 Anxiety Drug Data to be Presented at US Neuroscience Conference</title>
    <content type="html">Bionomics Limited (ASX: BNO, US OTC: BMICY) will today present new data at the 2010 Society for Neuroscience Annual Meeting in San Diego, Californis, demonstrating that the Company's anti-anxiety drug BNC210 is highly effective in preclinical models of drug-induced anxiety.</content>
    <updated>2012-07-02T04:28:28Z</updated>
    <author>
      <name>BioSA</name>
    </author>
  </entry>
</feed>
